Explore popular drugs in clinical trials

Check which drugs are currently being frequently studied.

See also our rare diseases glossary and popular diseases list.

Starting by letter

To open the drugs glossary, select a letter from the list below.

Most popular drugs

The list below features the most popular substances currently involved in ongoing clinical trials.

Drug Trials
Pembrolizumab 446
Sodium Chloride 411
Carboplatin 337
Cisplatin 282
Paclitaxel 250
Fluorouracil 232
Oxaliplatin 223
Nivolumab 209
Dexamethasone 204
Rituximab 194
Cyclophosphamide 186
Bevacizumab 161
Durvalumab 161
Capecitabine 156
Paracetamol 155
Atezolizumab 146
Docetaxel 128
Prednisone 127
Tocilizumab 124
Prednisolone 121
Gemcitabine 117
Venetoclax 116
Pemetrexed 114
Mycophenolate Mofetil 114
Etoposide 114
Doxorubicin Hydrochloride 108
Infliximab 98
Lenalidomide 98
Ipilimumab 90
Folinic Acid 89
Acetylsalicylic Acid 88
Semaglutide 88
Paclitaxel Albumin-Bound 84
Placebo 84
Cytarabine 79
Daratumumab 79
Calcium Folinate 78
Methotrexate 78
Fludarabine Phosphate 77
Letrozole 72
Bortezomib 71
Olaparib 70
Gemcitabine Hydrochloride 69
Obinutuzumab 67
Dapagliflozin 66
Azacitidine 66
Trastuzumab 65
Cetuximab 64
Tacrolimus 63
Fulvestrant 62
Lenvatinib 62
Methylprednisolone 61
Irinotecan 61
Irinotecan Hydrochloride Trihydrate 59
Temozolomide 59
Cemiplimab 57
Vincristine Sulfate 57
Trastuzumab Deruxtecan 53
Enzalutamide 51
Lidocaine Hydrochloride Monohydrate 50
Apixaban 50
Betamethasone Sodium Phosphate 50
Dexamethasone Sodium Phosphate 49
Codeine Phosphate 49
Amoxicillin 47
Buclizine Hydrochloride 47
Lidocaine Hydrochloride 46
Exemestane 46
Potassium Chloride 46
Empagliflozin 46
Hydrocortisone 45
Anastrozole 45
Adalimumab 45
Ribociclib 44
Doxorubicin 43
Pertuzumab 43
Clopidogrel 42
Oxygen 42
Clavulanic Acid 42
Pomalidomide 42
Tenofovir Alafenamide 41
Ruxolitinib 41
Ibrutinib 41
Rivaroxaban 41
Abemaciclib 40
Atorvastatin 40
Ropivacaine Hydrochloride 40
Sulfamethoxazole 39
Bendamustine Hydrochloride 39
Carfilzomib 39
Trimethoprim 39
Pemetrexed Disodium 38
Propofol 38
Palbociclib 38
Linezolid 38
Metformin Hydrochloride 38
Ifosfamide 38
Cyclophosphamide Monohydrate 37
Dexamethasone Acetate 37
Emtricitabine 37

New drugs in trials

The list below features the new substances involved to ongoing clinical trials.

#1 VMX-C001

Clinical trials are studying VMX-C001 in people who take a Factor Xa direct oral anticoagulant and need urgent surgery or another high-bleeding-risk procedure.

4 weeks ago
#2 LIPASE

Clinical trials are investigating LIPASE, including a new lipase product compared with pancrelipase.

4 weeks ago
#3 TRIACYLGLYCEROL LIPASE

Clinical trials of TRIACYLGLYCEROL LIPASE are studying a new lipase treatment in adults with exocrine pancreatic insufficiency.

4 weeks ago
#4 IMA401

Clinical trials are investigating IMA401 in patients with recurrent and/or refractory solid tumors.

4 weeks ago
#5 ALLERGEN EXTRACTS

Clinical trials are studying BLOMIA TROPICALIS POLYMERIZED EXTRACT as part of a vaccine for dust mite and Blomia tropicalis allergy.

4 weeks ago
#6 AUR200

Clinical trials are investigating AUR200 in people with generalized myasthenia gravis.

4 weeks ago

Drugs starting by n

  • Norucholic Acid

    ,

    Norucholic Acid, also known as norursodeoxycholic acid (norUDCA), is currently being studied in clinical trials for its potential to treat various liver conditions. This article explores two significant trials investigating the drug’s effectiveness in treating Non-alcoholic Steatohepatitis (NASH) and Primary Sclerosing Cholangitis (PSC). These studies aim to determine if Norucholic Acid can improve liver health and slow disease progression in patients with these challenging conditions.

  • Nusinersen

    ,

    Nusinersen, also known by its brand name Spinraza, is an innovative drug being studied in clinical trials for the treatment of spinal muscular atrophy (SMA). SMA is a genetic disorder that affects muscle strength and movement. This article explores the use of nusinersen in various clinical trials, its potential benefits, and what researchers are learning about its effectiveness and safety in treating different types of SMA.

  • Nvdx3

    ,

    NVDX3, an innovative osteogenic implant of human allogenic origin, is currently being studied in clinical trials for its potential in treating various bone-related conditions. These trials aim to evaluate the safety and efficacy of NVDX3 in patients with distal radius fractures and degenerative lumbar spondylolisthesis. The studies focus on long-term safety, bone formation, and clinical outcomes, offering hope for improved treatment options in orthopedic and spinal surgeries.

  • NVG-2089

    , ,

    NVG-2089 is an investigational drug currently being studied in clinical trials for patients with immune-related disorders, specifically Immune Thrombocytopenia (ITP) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). This novel treatment is designed to mimic the effects of a protein called IVIg by binding to specific receptors in the body, activating them to reduce inflammation and support immune system function. The ongoing clinical trials aim to evaluate the safety, tolerability, and efficacy of NVG-2089 in patients suffering from these challenging conditions. This article provides an overview of the current clinical trials and what they might mean for patients with these disorders.

  • Nvl-655

    ,

    Nvl-655, also known as Neladalkib, is an investigational drug currently being studied in clinical trials for patients with advanced ALK-positive non-small cell lung cancer (NSCLC) and other solid tumors. This article explores the ongoing research and potential benefits of Nvl-655 in treating these challenging conditions.

  • Nystatin

    , , , , ,

    Nystatin, a widely used antifungal medication, has been the subject of numerous clinical trials investigating its effectiveness in treating and preventing various medical conditions. This article explores the use of Nystatin in different clinical settings, from oral candidiasis prevention to its potential impact on systemic infections and even its role in HIV-related complications.